BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12091354)

  • 1. ATM mutations are rare in familial chronic lymphocytic leukemia.
    Yuille MR; Condie A; Hudson CD; Bradshaw PS; Stone EM; Matutes E; Catovsky D; Houlston RS
    Blood; 2002 Jul; 100(2):603-9. PubMed ID: 12091354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ataxia telangiectasia mutated-deficient B-cell chronic lymphocytic leukemia occurs in pregerminal center cells and results in defective damage response and unrepaired chromosome damage.
    Stankovic T; Stewart GS; Fegan C; Biggs P; Last J; Byrd PJ; Keenan RD; Moss PA; Taylor AM
    Blood; 2002 Jan; 99(1):300-9. PubMed ID: 11756185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATM mutations and protein expression are not associated with familial B-CLL cases.
    Ishibe N; Goldin LR; Caporaso NE; Sgambati MT; Dean M; Albitar M; Manshouri T; Gerrard B; Marti GE
    Leuk Res; 2003 Oct; 27(10):973-5. PubMed ID: 12860021
    [No Abstract]   [Full Text] [Related]  

  • 4. Linkage analysis for ATM in familial B cell chronic lymphocytic leukaemia.
    Bevan S; Catovsky D; Marossy A; Matutes E; Popat S; Antonovic P; Bell A; Berrebi A; Gaminara E; Quabeck K; Ribeiro I; Mauro FR; Stark P; Sykes H; van Dongen J; Wimperis J; Wright S; Yuille MR; Houlston RS
    Leukemia; 1999 Oct; 13(10):1497-500. PubMed ID: 10516748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variations of the ataxia telangiectasia mutated gene in patients with chronic lymphocytic leukemia lack substantial impact on progression-free survival and overall survival: a Cancer and Leukemia Group B study.
    Lozanski G; Ruppert AS; Heerema NA; Lozanski A; Lucas DM; Gordon A; Gribben JG; Morrison VA; Rai KM; Marcucci G; Larson RA; Byrd JC
    Leuk Lymphoma; 2012 Sep; 53(9):1743-8. PubMed ID: 22369572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATM mutations in sporadic lymphoid tumours.
    Stankovic T; Stewart GS; Byrd P; Fegan C; Moss PA; Taylor AM
    Leuk Lymphoma; 2002 Aug; 43(8):1563-71. PubMed ID: 12400598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia.
    Schaffner C; Stilgenbauer S; Rappold GA; Döhner H; Lichter P
    Blood; 1999 Jul; 94(2):748-53. PubMed ID: 10397742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and clinical implications of ATM aberrations in chronic lymphocytic leukemia.
    Ouillette P; Li J; Shaknovich R; Li Y; Melnick A; Shedden K; Malek SN
    Genes Chromosomes Cancer; 2012 Dec; 51(12):1125-32. PubMed ID: 22952040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATM mutations in B-cell chronic lymphocytic leukemia.
    Bullrich F; Rasio D; Kitada S; Starostik P; Kipps T; Keating M; Albitar M; Reed JC; Croce CM
    Cancer Res; 1999 Jan; 59(1):24-7. PubMed ID: 9892178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATM mutations are associated with inactivation of the ARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphoma.
    Grønbaek K; Worm J; Ralfkiaer E; Ahrenkiel V; Hokland P; Guldberg P
    Blood; 2002 Aug; 100(4):1430-7. PubMed ID: 12149228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ataxia telangiectasia gene mutations in leukaemia and lymphoma.
    Boultwood J
    J Clin Pathol; 2001 Jul; 54(7):512-6. PubMed ID: 11429421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the ATM gene lead to impaired overall and treatment-free survival that is independent of IGVH mutation status in patients with B-CLL.
    Austen B; Powell JE; Alvi A; Edwards I; Hooper L; Starczynski J; Taylor AM; Fegan C; Moss P; Stankovic T
    Blood; 2005 Nov; 106(9):3175-82. PubMed ID: 16014569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gene atm and chronic lymphocytic leukemia - review].
    Zhu DX; Xu W; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1242-6. PubMed ID: 18928637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion.
    Austen B; Skowronska A; Baker C; Powell JE; Gardiner A; Oscier D; Majid A; Dyer M; Siebert R; Taylor AM; Moss PA; Stankovic T
    J Clin Oncol; 2007 Dec; 25(34):5448-57. PubMed ID: 17968022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biallelic ATM inactivation significantly reduces survival in patients treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 trial.
    Skowronska A; Parker A; Ahmed G; Oldreive C; Davis Z; Richards S; Dyer M; Matutes E; Gonzalez D; Taylor AM; Moss P; Thomas P; Oscier D; Stankovic T
    J Clin Oncol; 2012 Dec; 30(36):4524-32. PubMed ID: 23091097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATM gene alterations in chronic lymphocytic leukemia patients induce a distinct gene expression profile and predict disease progression.
    Guarini A; Marinelli M; Tavolaro S; Bellacchio E; Magliozzi M; Chiaretti S; De Propris MS; Peragine N; Santangelo S; Paoloni F; Nanni M; Del Giudice I; Mauro FR; Torrente I; Foà R
    Haematologica; 2012 Jan; 97(1):47-55. PubMed ID: 21993670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy.
    Paglia LL; Laugé A; Weber J; Champ J; Cavaciuti E; Russo A; Viovy JL; Stoppa-Lyonnet D
    Breast Cancer Res Treat; 2010 Jan; 119(2):443-52. PubMed ID: 19404735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A putative "hepitype" in the ATM gene associated with chronic lymphocytic leukemia risk.
    Martín-Guerrero I; Enjuanes A; Richter J; Ammerpohl O; Colomer D; Ardanaz M; Marco F; Salas A; Campo E; Siebert R; García-Orad A
    Genes Chromosomes Cancer; 2011 Nov; 50(11):887-95. PubMed ID: 21910157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATM germline heterozygosity does not play a role in chronic lymphocytic leukemia initiation but influences rapid disease progression through loss of the remaining ATM allele.
    Skowronska A; Austen B; Powell JE; Weston V; Oscier DG; Dyer MJ; Matutes E; Pratt G; Fegan C; Moss P; Taylor MA; Stankovic T
    Haematologica; 2012 Jan; 97(1):142-6. PubMed ID: 21933854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inherited predisposition to chronic lymphocytic leukemia.
    Brown JR
    Expert Rev Hematol; 2008 Oct; 1(1):51-61. PubMed ID: 19802369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.